Skip to content
    TAK stock page

    TAKEDA PHARMACEUTICAL CO LTD

    TAK · earnings call history

    2 calls analysed
    1. Dec 2025Q3 FY26Jan 29, 2026

      Takeda Q3 FY26 — Strong Pipeline Progress Offsets VYVANSE LOE and Market Headwinds

      Read the brief
    2. Sep 2025Q2 FY26Oct 30, 2025

      Takeda Q2 FY25 — VYVANSE LOE Peaks, Pipeline Advances, and Innovent Partnership Bolsters Oncology

      Read the brief

    Browse all US companies on the earnings-call register.